Article info

Download PDFPDF

Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?
  1. Correspondence to Professor Neil Marlow, Neonatal Medicine, UCL EGA Institute for Women's Health, 74 Huntley Street, London WC1E 6AU, UK; n.marlow{at}ucl.ac.uk
View Full Text

Citation

Marlow N
Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?

Publication history

  • Received July 17, 2014
  • Revised September 4, 2014
  • Accepted September 10, 2014
  • First published October 10, 2014.
Online issue publication 
December 14, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.